The development of VTP-300 in chronic Hepatitis B (CHB) and VTP-1000 in celiac disease will be prioritized.The pipeline prioritization is expected to result in a reduction in workforce of approximately
Barinthus Biotherapeutics plc (NASDAQ:BRNS – Get Free Report) was the recipient of a large decline in short interest in May. As of May 15th, there was short interest totalling 9,100 shares, a decline of 52.1% from the April 30th total of 19,000 shares. Based on an average daily volume of 22,300 shares, the short-interest ratio […]
Barinthus Biotherapeutics plc (NASDAQ:BRNS – Get Free Report) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 9,100 shares, a drop of 52.1% from the April 30th total of 19,000 shares. Currently, 0.0% of the shares of the company are […]
Barinthus Bio to Present VTP-300 Clinical Data Updates at EASL Congress 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.